Viking Therapeutics, Inc. (VKTX): DEFA14A filed Apr 1, 2026

Form type

DEFA14A

Filing date

Apr 1, 2026

Accession number

0001193125-26-137924

Filer

Viking Therapeutics, Inc. (CIK 1607678)